Tag Archives: opioid

Mundipharma in deal to distribute Penthrox

Mundipharma has entered an exclusive Australian distribution agreement with Medical Developments International (MVP) for the non-opioid pain medication Penthrox (methoxyflurane). Penthrox is self-administered through a custom-built inhaler under the supervision of a treating healthcare practitioner and should bring pain relief in six to 10 breaths. It is indicated for short-term …

Read More »

Guild launches online opioid course

The Pharmacy Guild’s Learning and Development platform features a new online course, ‘Opioid substitution therapy: A guide for pharmacists’. The module includes the pharmacological basis for using substitution therapy, its benefits and aims for treatment. The course also provides preliminary information for pharmacists who wish to initiate an opioid substitution …

Read More »

Opioid crisis to explode

Proposed changes to the federal government’s Private Health Insurance (PHI) policy have reignited concerns over Australia’s opioid epidemic, with people to be denied access to pain management treatments unless they hold the top-tier ‘gold’ policy. This comes in the light of: Opioid-related deaths now exceeding heroin deaths by 2.5 times. …

Read More »